연구업적
Ki-Hong Jang, Yun-Ju Do, Tae-Sung Koo, Jun-Sub Choi, Eun Ju Song, Yeseong Hwang, Hyun Ju Bae, Ju-hee Lee, Eunhee Kim. Protective effect of RIPK1-inhibitory compound in in vivo models for retinal degenerative disease. Experimental Eye Research 180 (2019):8–17
Ki-Hong Janga, Taeik Janga, Eunji Sona, Soonjin Choib, Eunhee Kim. Kinase-independent role of nuclear RIPK1 in regulating parthanatos through physical interaction with PARP1 upon oxidative stress. BBA - Molecular Cell Research 1865 (2018):132–141
Yun-Ju Do, Seo Young Yun, Min-Young Park and Eunhee Kim. The M458L missense mutation disrupts the catalytic properties of Parkin FEBS Letters. 592 (2018):78–88
Soo-Jin Kim, Eunhee Kim & Kyung-Taek Rim*. Comparative analysis of Adam33 mutations in murine lung cancer cell lines by droplet digital PCR, real-time PCR and Insight OncoTM NGS Mol Cell Toxicol. 2018 14:221-231
Changsun Yu, Bok-seok Kim, Minyoung Park, Yun-Ju Do, Young-Yun Kong and Eunhee Kim*. FAF1 mediates necrosis through JNK1-mediated mitochondrial dysfunction leading to retinal degeneration in the ganglion cell layer upon ischemic insult. Cell Communication and Signaling. 2018:16-56
KH Jang, YJ Do, D Son, E Son, JS Choi, E Kim*. AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration. Cell Death Dis. 2017 Jan ;8, e2526
Yang SJ, Park YS, Cho JH, Moon B, An HJ, Lee JY, Xie Z, Wang Y, Pocalyko D, Lee DC, Sohn HA, Kang M, Kim JY, Kim E, Park KC, Kim JA, Yeom YI. Regulation of hypoxia responses by flavin adenine dinucleotide-dependent modulation of HIF-1α protein stability. EMBO J. 2017 Apr 13;36(8):1011-1028.
JH Kim, ME Park, Chamilani Nikapitiya, TH Kim, Md Bashir Uddin, HC Lee, E Kim, JY Ma, JU. Jung, CJ Kim, JS Lee. FAS-associated factor-1 positively regulates type I interferon response to RNA virus infection by targeting NLRX1. PLoS Pathog. 2017 May 13(5): e1006398
C Yu, B Kim, E Kim*. FAF1 mediates regulated necrosis through PARP1 activation upon oxidative stress leading to dopaminergic neurodegeneration. Cell Death Differ. 2016 Sep ;23, 1873-85
JY Choi, CY Hwang, BR Lee, SM Lee, YJ Bahn, KP Lee, MK Kang, YS Kim, SH Woo, JY Lim, E Kim, Ki-Sun Kwon. Age-associated repression of type 1 inositol 1, 4, 5-triphosphate receptor impairs muscle regeneration. Aging (Albany NY). 2016 Sep; 8(9): 2062–2076.
JW Jeong, C Yu, JH Lee, KS Moon, E Kim, SE Yoo*, TS Koo** (2016). Subacute toxicity evaluation of KR-33493, FAF1 inhibitor for a new anti-parkinson's disease agent, after oral administration in rats and dogs. Regulatory Toxicology and Pharmacology, 81, 387-396.
Yoo SE *, Yu C, Jung S, Kim E, Kang NS* (2016). Design and synthesis of fluorescent and biotin tagged probes for the study of molecular actions of FAF1 inhibitor. Bioorganic & medicinal chemistry letters, 26(4), 1169-1172.
M Park, I won Park, C hwa Ihm, E Kim*. PARK2 gene variants in Korean patients with Parkinson’s disease. GENES & GENOMICS. (2016)38: 163.163-169.
Song EJ, Do YJ, Lee MH, Kim E*, Kang NS*. Discovery of structural characteristics of RIP1K for activity control using the combination method. J. Mol. Struct. 2015 Nov ;1100, 272-8
Kim TW, Kang YK, Park ZY, Kim YH, Hong SW, Oh SJ, Sohn HA, Yang SJ, Jang YJ, Lee DC, Kim SY, Yoo HS, Kim E, Yeom YI, Park KC. SH3RF2 functions as an oncogene by mediating PAK4 protein stability. Carcinogenesis. 2014 Mar;35(3):624-634.
Sul JW, Park MY, Shin J, Kim YR, Yoo SE, Kong YY, Kwon KS, Lee YH, Kim E*. Accumulation of the parkin substrate, FAF1, plays a key role in the dopaminergic neurodegeneration. Hum Mol Genet. 2013 Jan
K.W. Cho, J.H. Park, C.W. Park, D. Lee, E. Lee, D.J. Kim, K.J. Kim, S.H. Yoon, Y. Park, E. Kim, S. Cho, S. Jang, B.C. Park, S.W. Chi, S.H. Yoo, M.H. Jang, H.N. Kim, Kim E, K. Jo, Y.W. Park, Identification of a pivotal endocytosis motif in c-Met and selective modulation of HGF-dependent aggressiveness of cancer using the 16-mer endocytic peptide. Oncogene, 32 (2013) 1018-1029.
Cho KW, Park JH, Park CW, Lee D, Lee E, Kim DJ, Kim KJ, Yoon SH, Park Y, Kim E, Cho S, Jang S, Park BC, Chi SW, Yoo SH, Jang MH, Kim HN, Kim E, Jo K, Park YW. Identification of a pivotal endocytosis motif in c-Met and selective modulation of HGF-dependent aggressiveness of cancer using the 16-mer endocytic peptide. Oncogene. 2013 Feb 21;32(8):1018-29.
Lee YS, Dayma Y, Park MY, Kim KI, Yoo SE, Kim E*. Daxx is a key downstream component of receptor interacting protein kinase 3 mediating retinal ischemic cell death. FEBS Lett. 2013 Jan ;587(3):266-71